Fulcrum Therapeutics (FULC) PT Raised to $12 at Morgan Stanley
Tweet
Share
E-mailGet Alerts FULC Hot Sheet
Price: $7.28 -2.15%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 14
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Fulcrum Therapeutics (NASDAQ: FULC) to $12.00 (from $11.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Boston Scientific (BSX) PT Raised to $83 at Stifel
- Citi Upgrades United Microelectronics Corp (2303:TT) (UMC) to Buy 'with limited downside'
- Goldman Sachs Downgrades Zhejiang Huayou Cobalt Co Ltd. (603799:CH) to Sell
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
